(BUD) – Analyzing Anheuser-Busch InBev’s Short Interest

Anheuser-Busch InBev’s (NYSE:BUD) short percent of float has fallen 14.0% since its last report. The company recently reported that it has 7.37 million shares sold short, which is 0.43% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.09 days to cover their short positions on […]

Peering Into Boston Scientific’s Recent Short Interest

Boston Scientific’s (NYSE:BSX) short percent of float has fallen 29.07% since its last report. The company recently reported that it has 8.72 million shares sold short, which is 0.61% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.21 days to cover their short positions on […]

Looking Into Bristol-Myers Squibb’s Recent Short Interest

Bristol-Myers Squibb’s (NYSE:BMY) short percent of float has fallen 3.33% since its last report. The company recently reported that it has 18.34 million shares sold short, which is 0.87% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.63 days to cover their short positions on […]

Teva’s Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale.  This news comes from individuals privy to the matter, who indicated that the current healthcare asset acquisitions continue despite the broader global slowdown in dealmaking.  Working with consultants, Teva is attempting […]